Nicola Ooi

471 total citations
15 papers, 366 citations indexed

About

Nicola Ooi is a scholar working on Molecular Biology, Molecular Medicine and Organic Chemistry. According to data from OpenAlex, Nicola Ooi has authored 15 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Molecular Medicine and 4 papers in Organic Chemistry. Recurrent topics in Nicola Ooi's work include Antibiotic Resistance in Bacteria (6 papers), Cancer therapeutics and mechanisms (4 papers) and Bacterial biofilms and quorum sensing (3 papers). Nicola Ooi is often cited by papers focused on Antibiotic Resistance in Bacteria (6 papers), Cancer therapeutics and mechanisms (4 papers) and Bacterial biofilms and quorum sensing (3 papers). Nicola Ooi collaborates with scholars based in United Kingdom and Sweden. Nicola Ooi's co-authors include I. Chopra, Alex J. O’Neill, Keith Miller, W. Love, W. Rhys‐Williams, Christopher P. Randall, Jonathan H. Cove, Joanne K. Hobbs, R.A. Bojar and Jennifer L. Cottell and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Genome biology and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Nicola Ooi

13 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicola Ooi United Kingdom 10 218 116 93 76 65 15 366
Meghan S. Blackledge United States 12 294 1.3× 97 0.8× 94 1.0× 85 1.1× 69 1.1× 19 477
Victoria J. Savage United Kingdom 8 273 1.3× 103 0.9× 99 1.1× 83 1.1× 77 1.2× 11 407
Daina Zeng United States 9 220 1.0× 136 1.2× 97 1.0× 61 0.8× 76 1.2× 12 447
Weiliang Zeng China 16 172 0.8× 221 1.9× 91 1.0× 62 0.8× 37 0.6× 31 431
Letícia Ramos Dantas Brazil 7 224 1.0× 93 0.8× 59 0.6× 49 0.6× 49 0.8× 20 418
Kevin C. Ludwig Germany 8 201 0.9× 73 0.6× 94 1.0× 135 1.8× 32 0.5× 12 362
Rafael Ayerbe-Algaba Spain 10 210 1.0× 248 2.1× 85 0.9× 66 0.9× 64 1.0× 17 540
S. Adline Princy India 14 275 1.3× 58 0.5× 149 1.6× 78 1.0× 28 0.4× 31 417
Sunniva Foerster Sweden 9 179 0.8× 149 1.3× 52 0.6× 194 2.6× 51 0.8× 10 571
Rebecca Weiser United Kingdom 12 193 0.9× 95 0.8× 92 1.0× 46 0.6× 66 1.0× 24 454

Countries citing papers authored by Nicola Ooi

Since Specialization
Citations

This map shows the geographic impact of Nicola Ooi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicola Ooi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicola Ooi more than expected).

Fields of papers citing papers by Nicola Ooi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicola Ooi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicola Ooi. The network helps show where Nicola Ooi may publish in the future.

Co-authorship network of co-authors of Nicola Ooi

This figure shows the co-authorship network connecting the top 25 collaborators of Nicola Ooi. A scholar is included among the top collaborators of Nicola Ooi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicola Ooi. Nicola Ooi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
2.
Ooi, Nicola, Brendan P. Norman, James A. Gallagher, et al.. (2023). Evaluation of Homogentisic Acid, a Prospective Antibacterial Agent Highlighted by the Suitability of Nitisinone in Alkaptonuria 2 (SONIA 2) Clinical Trial. Cells. 12(13). 1683–1683. 1 indexed citations
3.
Whelan, Adam O., Nicola Ooi, David Orr, et al.. (2023). In Vitro Activity of Novel Topoisomerase Inhibitors against Francisella tularensis and Burkholderia pseudomallei. Antibiotics. 12(6). 983–983. 1 indexed citations
4.
Ooi, Nicola, et al.. (2020). Restoring carbapenem efficacy: a novel carbapenem companion targeting metallo-β-lactamases in carbapenem-resistant Enterobacterales. Journal of Antimicrobial Chemotherapy. 76(2). 460–466. 13 indexed citations
5.
Yokoyama, Maho, Emily J. Stevens, Maisem Laabei, et al.. (2018). Epistasis analysis uncovers hidden antibiotic resistance-associated fitness costs hampering the evolution of MRSA. Genome biology. 19(1). 94–94. 29 indexed citations
6.
Randall, Christopher P., et al.. (2017). Cryptic silver resistance is prevalent and readily activated in certain Gram-negative pathogens. Journal of Antimicrobial Chemotherapy. 72(11). 3043–3046. 29 indexed citations
7.
Charrier, Cédric, Victoria J. Savage, Thomas P. Duffy, et al.. (2017). Novel Bacterial Topoisomerase Inhibitors with Potent Broad-Spectrum Activity against Drug-Resistant Bacteria. Antimicrobial Agents and Chemotherapy. 61(5). 37 indexed citations
8.
Charrier, Cédric, Anne‐Marie Salisbury, Victoria J. Savage, et al.. (2016). In vitrobiological evaluation of novel broad-spectrum isothiazolone inhibitors of bacterial type II topoisomerases. Journal of Antimicrobial Chemotherapy. 71(10). 2831–2839. 6 indexed citations
9.
Ooi, Nicola, et al.. (2016). Tert-butyl benzoquinone: mechanism of biofilm eradication and potential for use as a topical antibiofilm agent. Journal of Antimicrobial Chemotherapy. 71(7). 1841–1844. 11 indexed citations
10.
Ooi, Nicola & Alex J. O’Neill. (2016). Revisiting unexploited antibiotics in search of new antibacterial drug candidates: the case of MSD-819 (6-chloro-2-quinoxalinecarboxylic acid 1,4-dioxide). The Journal of Antibiotics. 70(3). 317–319. 6 indexed citations
11.
Ooi, Nicola, et al.. (2014). Redox-active compounds with a history of human use: antistaphylococcal action and potential for repurposing as topical antibiofilm agents. Journal of Antimicrobial Chemotherapy. 70(2). 479–488. 33 indexed citations
12.
Ooi, Nicola, I. Chopra, E. Anne Eady, et al.. (2013). Antibacterial activity and mode of action of tert-butylhydroquinone (TBHQ) and its oxidation product, tert-butylbenzoquinone (TBBQ). Journal of Antimicrobial Chemotherapy. 68(6). 1297–1304. 33 indexed citations
13.
Ooi, Nicola, et al.. (2011). Further Characterization of Bacillus subtilis Antibiotic Biosensors and Their Use for Antibacterial Mode-of-Action Studies. Antimicrobial Agents and Chemotherapy. 55(4). 1784–1786. 12 indexed citations
14.
Ooi, Nicola, Keith Miller, Joanne K. Hobbs, et al.. (2009). XF-73, a novel antistaphylococcal membrane-active agent with rapid bactericidal activity. Journal of Antimicrobial Chemotherapy. 64(4). 735–740. 77 indexed citations
15.
Ooi, Nicola, Keith Miller, Christopher P. Randall, et al.. (2009). XF-70 and XF-73, novel antibacterial agents active against slow-growing and non-dividing cultures of Staphylococcus aureus including biofilms. Journal of Antimicrobial Chemotherapy. 65(1). 72–78. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026